{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:27:38Z","timestamp":1794853658030,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      , once considered benign species, is recently being recognised to be causing severe malaria like\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      . In the present study, the authors report the trends in malaria severity in\n                      <jats:italic>P. vivax<\/jats:italic>\n                      among patients from a Delhi government hospital. The aim of the study was to understand the disease severity and the burden of severe vivax malaria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A hospital based study was carried out from June 2017 to December 2018 at a tertiary care centre from Delhi, India. Patients were tested for malaria using peripheral blood smear (PBS) and\/or rapid malaria antigen test (RMAT). The severe and non-severe vivax malaria categorization was done as per the WHO guidelines. Sociodemographic, clinic and paraclinical data were collected from patients and their medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 205 patients, 177 (86.3%) had\n                      <jats:italic>P. vivax<\/jats:italic>\n                      infection, 22 (10.7%) had\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      infection and six (2.9%) had mixed infection with both the species. Out of 177\n                      <jats:italic>P. vivax<\/jats:italic>\n                      cases included in this study one or more manifestations of severe malaria was found in 58 cases (32.7%). Severe anaemia (56.9%), jaundice (15%) and significant bleeding (15%) were the most common complications reported in most of patients, along with thrombocytopenia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this study, it is evident that vivax malaria is emerging as the new severe disease in malaria patients, a significant shift in the paradigm of\n                      <jats:italic>P. vivax<\/jats:italic>\n                      pathogenesis. The spectrum of complications and alterations in the laboratory parameters in\n                      <jats:italic>P. vivax<\/jats:italic>\n                      clinical cases also indicate the recent shift in the disease severity.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-020-00393-9","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T14:03:18Z","timestamp":1604066598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India"],"prefix":"10.1186","volume":"19","author":[{"given":"Monika","family":"Matlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loick P.","family":"Kojom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelangi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"393_CR1","unstructured":"WHO. World malaria report 2019. 2019; 1\u2013282. \nwww.who.int\n\n."},{"key":"393_CR2","unstructured":"WHO. World Malaria Report 2014. 2014; pp. 1\u2013242. \nwww.who.int\n\n."},{"key":"393_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"Cowman","year":"2016","unstructured":"Cowman, et al. Malaria: biology and disease. Cell. 2016;167:610\u201324. \nhttps:\/\/doi.org\/10.1016\/j.cell.2016.07.055\n\n.","journal-title":"Cell"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18]30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Pyae Phyo A, Woodrow C. Malaria. Lancet. 2018;391:1608\u201321. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(18]30324-6\n\n.","journal-title":"Lancet"},{"key":"393_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","volume":"80","author":"NM Anstey","year":"2012","unstructured":"Anstey NM, Douglas MN, Poespoprodjo JR, Price RN. Plasmodium vivax: Clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151\u2013201. \nhttps:\/\/doi.org\/10.1016\/B978-0-12-397900-1.00003-7\n\n.","journal-title":"Adv Parasitol"},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cid\/cix437","volume":"65","author":"K Wyss","year":"2017","unstructured":"Wyss K, Wangdahl A, Vesterlund M, Hammar U, Dashti S, Naucher P, et al. Obesity and diabetes as risk factors for severe Plasmodium falciparum malaria: results from a Swedish Nationwide study. Clin Infect Dis. 2017;65:949\u201358. \nhttps:\/\/doi.org\/10.1093\/cid\/cix437\n\n.","journal-title":"Clin Infect Dis"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12916-020-1497-0","volume":"18","author":"S Dini","year":"2020","unstructured":"Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, et al. The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study. BMC Med. 2020;18:28. \nhttps:\/\/doi.org\/10.1186\/s12916-020-1497-0\n\n.","journal-title":"BMC Med"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1475-2875-13-481","volume":"13","author":"BA Rahimi","year":"2014","unstructured":"Rahimi BA, Thakkinstian A, White NJ, Sirivichavakul C, Dondorp AM, Chokejindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481. \nhttps:\/\/doi.org\/10.1186\/1475-2875-13-481\n\n.","journal-title":"Malar J."},{"key":"393_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4269\/ajtmh.16-0163","volume":"95","author":"AR Anivkar","year":"2016","unstructured":"Anivkar AR, Shah N, Dhariwal AC, Singh Sonal G, Mohan Pradhan M, Ghosh SK, et al. Epidemiology of Plasmodium vivax malaria in India. Am J Trop Med Hyg. 2016;95:108\u201320. \nhttps:\/\/doi.org\/10.4269\/ajtmh.16-0163\n\n.","journal-title":"Am J Trop Med Hyg"},{"key":"393_CR10","doi-asserted-by":"crossref","unstructured":"Ghosh SK, Rahi M. Malaria elimination in India\u2014the way forward. J Vector Borne Dis 2019;56:32\u201340. \nhttps:\/\/www.jvbd.org\/text.asp?2019\/56\/1\/32\/257771","DOI":"10.4103\/0972-9062.257771"},{"key":"393_CR11","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.18203\/2394-6040.ijcmph20184827","volume":"12","author":"G Yadav","year":"2018","unstructured":"Yadav G, Pardeshi G, Roy N. Clinico-epidemiological profile of patients admitted with Plasmodium vivax malaria in a tertiary care hospital, Delhi. Int J Comm Med Public Health. 2018;12:5420\u20134.","journal-title":"Int J Comm Med Public Health"},{"key":"393_CR12","first-page":"37","volume":"13","author":"N Singh","year":"2014","unstructured":"Singh N, Mathur A, Naim F, Agarwal N. The changing clinical spectrum of malaria: a clinical study from Bundelkhand. IOSR J Dental Med Sci. 2014;13:37\u201340.","journal-title":"IOSR J Dental Med Sci"},{"key":"393_CR13","unstructured":"National Vector Borne Disease Control Program. Epidemiological situation Report in India. \nhttps:\/\/nvbdcp.gov.in\/Doc\/Annual-Report-2017.pdf"},{"key":"393_CR14","unstructured":"National Vector Borne Disease Control Program. Endemicity of malaria from 2016 to 2018. \nwww.nvbdcp.gov.in"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/cmr.15.1.66-78.2002","volume":"15","author":"A Moody","year":"2002","unstructured":"Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002;15:66\u201378. \nhttps:\/\/doi.org\/10.1128\/cmr.15.1.66-78.2002\n\n.","journal-title":"Clin Microbiol Rev"},{"key":"393_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0035-9203(85)90329-3","volume":"79","author":"J-F Trape","year":"1985","unstructured":"Trape J-F. Rapid evaluation of malaria parasite density and standardization of thick smear examination for epidemiological investigations. Trans R Soc Trop Med Hyg. 1985;79:181\u20134. \nhttps:\/\/doi.org\/10.1016\/0035-9203(85)90329-3\n\n.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"393_CR17","unstructured":"WHO. Guidelines for the treatment of malaria\u2014third edition. \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK294440\/pdf\/Bookshelf_NBK294440.pdf\n\n (2015)."},{"key":"393_CR18","unstructured":"NIMR and NVBDCP. Guidelines on diagnosis and treatment of malaria in India, 2014. 2014, Third edition, vol 113: 20 pages. \nhttps:\/\/www.slideshare.net\/Dr_Padmesh\/malaria-guidelines-2014"},{"key":"393_CR19","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18]30324-6","volume":"391","author":"NJ White","year":"2014","unstructured":"White NJ. Malaria Lancet. 2014;391:1608\u201321. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(18]30324-6\n\n.","journal-title":"Malaria Lancet"},{"key":"393_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4161\/viru.19013","volume":"3","author":"L R\u00e9nia","year":"2012","unstructured":"R\u00e9nia L, Howland SW, Claser C, Gruner AC, Suwanarusk R, Teo TH, et al. Cerebral malaria: mysteries at the blood-brain barrier. Virulence. 2012;3:193\u2013201. \nhttps:\/\/doi.org\/10.4161\/viru.19013\n\n.","journal-title":"Virulence"},{"key":"393_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1086\/654815","volume":"202","author":"BO Carvalho","year":"2010","unstructured":"Carvalho BO, Lopes SCP, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, Mamoni R, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202:638\u201347.","journal-title":"J Infect Dis"},{"key":"393_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3389\/fimmu.2017.01148","volume":"8","author":"PR Totino","year":"2017","unstructured":"Totino PR, Lopes SC. Insights into the cytoadherence phenomenon of Plasmodium vivax: The putative role of phosphatidylserine. Front Immunol. 2017;8:1148. \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.01148\n\n.","journal-title":"Front Immunol"},{"key":"393_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1179\/102453312X13221316477336","volume":"17","author":"KS Akinosoglou","year":"2012","unstructured":"Akinosoglou KS, Solomou EE, Gogos CA. Malaria: a haematological disease. Hematol. 2012;17:106\u201314. \nhttps:\/\/doi.org\/10.1179\/102453312X13221316477336\n\n.","journal-title":"Hematol"},{"key":"393_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fimmu.2017.00126","volume":"8","author":"C L\u00f3pez","year":"2017","unstructured":"L\u00f3pez C, Yepes-P\u00e9rez Y, Hincapi\u00e9-Escobar N, D\u00edaz-Ar\u00e9valo D, Patarroyo MA. What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates\u202f? Front Immunol. 2017;8:126. \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.00126\n\n.","journal-title":"Front Immunol"},{"key":"393_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4269\/ajtmh.2009.80.194","volume":"80","author":"DK Kochar","year":"2009","unstructured":"Kochar DK, Das A, Kochar SK, Saxsena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in Northwestern India. Am J Trop Med Hyg. 2009;80:194\u20138. \nhttps:\/\/doi.org\/10.4269\/ajtmh.2009.80.194\n\n.","journal-title":"Am J Trop Med Hyg"},{"key":"393_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12936-016-1619-5","volume":"15","author":"L Chery","year":"2016","unstructured":"Chery L, Maki JN, Mascarenhas A, Walke JT, Gawas P, Almeida A, et al. Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India. Malar J. 2016;15:569. \nhttps:\/\/doi.org\/10.1186\/s12936-016-1619-5\n\n.","journal-title":"Malar J"},{"key":"393_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1179\/2047773213Y.0000000096","volume":"107","author":"VK Gehlawat","year":"2013","unstructured":"Gehlawat VK, Arya V, Kaushik JS, Gathwala G. Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health. 2013;107:210\u20134. \nhttps:\/\/doi.org\/10.1179\/2047773213Y.0000000096\n\n.","journal-title":"Pathog Glob Health"},{"key":"393_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/765657","volume":"2014","author":"M Kumari","year":"2014","unstructured":"Kumari M, Ghildiyal R. Clinical profile of Plasmodium vivax malaria in children and study of severity parameters in relation to mortality: a tertiary care centre perspective in Mumbai. India Malar Res Treat. 2014;2014:1\u20136.","journal-title":"India Malar Res Treat"},{"key":"393_CR29","first-page":"384","volume":"21","author":"HM Meena","year":"2017","unstructured":"Meena HM, Sharma BS, Gupta ML, Sharma A, Choudhary R, Sharma P. Clinico-laboratorical spectrum of malaria in children: emerging new trends. Curr Pediatr Res. 2017;21:384\u20138.","journal-title":"Curr Pediatr Res"},{"key":"393_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/tp.TP_2_19","volume":"9","author":"SE Mathews","year":"2019","unstructured":"Mathews SE, Bhagwati MM, Agnihotri V. Clinical spectrum of Plasmodium vivax infection, from benign to severe malaria: a tertiary care prospective study in adults from Delhi, India. Trop Parasitol. 2019;9:88\u201392. \nhttps:\/\/doi.org\/10.4103\/tp.TP_2_19\n\n.","journal-title":"Trop Parasitol"},{"key":"393_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1080\/21505594.2020.1773107","volume":"11","author":"AR Anvikar","year":"2020","unstructured":"Anvikar AR, van Eijk AM, Shah A, Upadhyay KJ, Sullivan SA, Patel AJ, et al. Clinical and epidemiologicalcharacterization of severe Plasmodium vivaxmalaria in Gujarat, India. Virulence. 2020;11:730\u20138. \nhttps:\/\/doi.org\/10.1080\/21505594.2020.1773107\n\n.","journal-title":"Virulence"},{"key":"393_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12936-018-2462-7","volume":"17","author":"PP Gai","year":"2018","unstructured":"Gai PP, Mockenhaupt FP, Siegert K, Wedam J, Boloor A, Kulkarni SS, et al. Manifestation of malaria in Mangaluru, southern India. MalarJ. 2018;17:313. \nhttps:\/\/doi.org\/10.1186\/s12936-018-2462-7\n\n.","journal-title":"MalarJ"},{"key":"393_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12936-017-1684-4","volume":"16","author":"JH Im","year":"2017","unstructured":"Im JH, Yoon Kwon H, Wook Park S, Durey A, Hee Lee K, Chung M-H, et al. Severe Plasmodium vivax infection in Korea. Malar J. 2017;16:51. \nhttps:\/\/doi.org\/10.1186\/s12936-017-1684-4\n\n.","journal-title":"Malar J"},{"key":"393_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1240962","author":"G Geleta","year":"2016","unstructured":"Geleta G, Ketema T. Severe malaria associated with Plasmodium falciparum and P. vivax among children in Pawe hospital. Northwest Ethiopia Malar Res Treat. 2016. \nhttps:\/\/doi.org\/10.1155\/2016\/1240962\n\n.","journal-title":"Northwest Ethiopia. Malar Res Treat."},{"key":"393_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/1471-2458-13-637","volume":"13","author":"T Ketema","year":"2013","unstructured":"Ketema T, Bacha K. Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health. 2013;13:637. \nhttps:\/\/doi.org\/10.1186\/1471-2458-13-637\n\n.","journal-title":"BMC Public Health"},{"key":"393_CR36","doi-asserted-by":"publisher","first-page":"e1001575","DOI":"10.1371\/journal.pmed.1001575","volume":"10","author":"NM Douglas","year":"2013","unstructured":"Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, et al. Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study. PLoS Med. 2013;10:e1001575. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.1001575\n\n.","journal-title":"PLoS Med"},{"key":"393_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135. \nhttps:\/\/doi.org\/10.1186\/1475-2875-11-135\n\n.","journal-title":"Malar J"},{"key":"393_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pt.2011.01.007","volume":"27","author":"AJ Umbers","year":"2011","unstructured":"Umbers AJ, Aitken EH, Rogerson SJ. Malaria in pregnancy: small babies, big problem. Trends Parasitol. 2011;27:168\u201375. \nhttps:\/\/doi.org\/10.1016\/j.pt.2011.01.007\n\n.","journal-title":"Trends Parasitol"},{"key":"393_CR39","doi-asserted-by":"publisher","first-page":"e31411","DOI":"10.1371\/journal.pone.0031411","volume":"7","author":"MJ Rijken","year":"2012","unstructured":"Rijken MJ, Papageorghiou AT, Thiptharakun S, Kiricharoen S, Dwell SLM, Wiladphaingern J, et al. Ultrasound evidence of early fetal growth restriction after maternal malaria infection. PLoS ONE. 2012;7:e31411. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0031411\n\n.","journal-title":"PLoS ONE"},{"key":"393_CR40","doi-asserted-by":"publisher","first-page":"QC01","DOI":"10.7860\/JCDR\/2017\/23051.9195","volume":"11","author":"M Datta","year":"2017","unstructured":"Datta M, Biswas J, Dasgupta S, Banerjee K, Choudhury S, Sengupta SK, et al. Comparative study on antenatal and perinatal outcome of vivax and falciparum malaria in a tertiary care hospital of Kolkata India. J Clin Diag Res. 2017;11:QC01-4. \nhttps:\/\/doi.org\/10.7860\/JCDR\/2017\/23051.9195\n\n.","journal-title":"J Clin Diag Res"},{"key":"393_CR41","doi-asserted-by":"publisher","first-page":"3076311","DOI":"10.5455\/jrmds.20153414","volume":"3","author":"M Hirani","year":"2015","unstructured":"Hirani M, Vadhvana SK. Study of clinical profile of P. vivax malaria in pregnancy. J Res Med Dental Sci. 2015;3:3076311. \nhttps:\/\/doi.org\/10.5455\/jrmds.20153414\n\n.","journal-title":"J Res Med Dental Sci."},{"key":"393_CR42","doi-asserted-by":"publisher","first-page":"e0005606","DOI":"10.1371\/journal.pntd.0005606","volume":"11","author":"A Bardaj\u00ed","year":"2017","unstructured":"Bardaj\u00ed A, Martinez-Espinosa FE, Ar\u00e9valo-Herrera M, Padilla N, Kochar S, Ome-Kaius M, et al. Burden and impact of Plasmodium vivax in pregnancy: a multi-centre prospective observational study. PLoS Negl Trop Dis. 2017;11:e0005606. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0005606\n\n.","journal-title":"PLoS Negl Trop Dis"},{"key":"393_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4269\/ajtmh.2001.65.614","volume":"65","author":"RN Price","year":"2001","unstructured":"Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, Ter Kuile F, et al. Factors contribution to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65:614\u201322. \nhttps:\/\/doi.org\/10.4269\/ajtmh.2001.65.614\n\n.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-020-00393-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T14:09:16Z","timestamp":1604066956000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-020-00393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/s12941-020-00393-9","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was taken by the Ethics Committee before the commencement of the study [IEC\/SJH\/VMMC\/Project\/2017\/983]. A written informed consent was obtained from each study participant or guardian of the wards and confidentiality of the participant\u2019s test results was ensured throughout the research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication of the present paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}